THE EFFICACY AND TOLERABILITY OF TARAFENACIN, A NEW MUSCARINIC ACETYLCHOLINE RECEPTOR M3 ANTAGONIST IN PATIENTS WITH OVERACTIVE BLADDER; RANDOMIZED, DOUBLE- BLIND, PLACEBO-CONTROLLED PHASE 2 STUDY

  • PARK WON HEE
제목
THE EFFICACY AND TOLERABILITY OF TARAFENACIN, A NEW MUSCARINIC ACETYLCHOLINE RECEPTOR M3 ANTAGONIST IN PATIENTS WITH OVERACTIVE BLADDER; RANDOMIZED, DOUBLE- BLIND, PLACEBO-CONTROLLED PHASE 2 STUDY
저자
PARK WON HEE
학회명
44th Annual Meeting of the International Continence Society(ICS)